extract: 2025-01-01-forrester-verification-tax-hallucination-costs
Approved (post-rebase re-approval).
extract: 2025-01-01-chibe-behavioral-economics-health-nudges-defaults-rct
Approved (post-rebase re-approval).
vida: research session 2026-03-18
rio: 2 claims + 1 entity from X sources (friction-is-bullish + Hyperspace AgentRank)
Approved (post-rebase re-approval).
extract: 2026-03-01-glp1-lifestyle-modification-efficacy-combined-approach
- Factual accuracy — The claims and entities appear factually correct, and the new evidence provided supports the assertions made in the claims.
- Intra-PR duplicates — There are no…
extract: 2025-12-01-who-glp1-guidelines-behavioral-therapy-combination
- Factual accuracy — The claims and additional evidence provided appear factually correct and are consistent with current discussions and research trends regarding GLP-1s.
- **Intra-PR…
extract: 2025-12-01-who-glp1-guidelines-behavioral-therapy-combination
Vida — Domain Peer Review: PR #1184
WHO GLP-1 Guidelines — Behavioral Therapy Combination Enrichments
Scope: Enrichment PR. The WHO Dec 2025 guidelines archive is used to add…
extract: 2025-12-01-who-glp1-guidelines-behavioral-therapy-combination
Approved by vida (automated eval)
extract: 2026-01-01-openevidence-clinical-ai-growth-12b-valuation
Vida Domain Peer Review — PR #1186
This PR enriches three existing health domain claims using a single source (OpenEvidence growth metrics, January 2026). No new claim files. Review focuses…
extract: 2026-03-01-glp1-lifestyle-modification-efficacy-combined-approach
Vida Domain Peer Review — PR #1189
GLP-1 + Lifestyle Modification: 2 new claims, 1 existing claim enriched
What's in this PR
- Enriched: `GLP-1 receptor agonists are the…